Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | BCHE | P06276 | 2/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | BACE1 | P56817 | 1/20 | 0.49 |
| ▸ | STS | P08842 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 6/20 | 0.48 |
| ▸ | CA2 | P00918 | 6/20 | 0.48 |
| ▸ | CA9 | Q16790 | 5/20 | 0.48 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | CTRC | Q99895 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.43 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29449523 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS | |
| SCHEMBL29358008 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS | |
| SCHEMBL5140714 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS | |
| SCHEMBL5140713 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS | |
| SCHEMBL18435791 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS | |
| SCHEMBL25345094 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS | |
| SCHEMBL4340521 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS | |
| SCHEMBL2547872 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS | |
| SCHEMBL22493841 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS | |
| SCHEMBL30290770 | 1.00 | L3MBTL1 (1.00) | L3MBTL1BCHEACHEBACE1STS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12214339-B2 | Nanocage-confined catalyst, preparation process and use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2025-02-04 | — | — | US | disclosed |
| EP-3831478-B1 | NANOCAGED CATALYST, PREPARATION METHOD, AND APPLICATION | CHINA PETROLEUM & CHEM CORP (CN) | 2024-11-27 | — | — | EP | disclosed |
| US-20210299644-A1 | Nanocage-confined catalyst, preparation process and use thereof | SHANGHAI RESEARCH INSTITUTE OF PETROCHEMICAL TECHNOLOGY, SINOPEC (CN) | 2021-09-30 | — | — | US | disclosed |
| EP-3831478-A1 | NANOCAGED CATALYST, PREPARATION METHOD, AND APPLICATION | China Petroleum & Chemical Corporation (CN) | 2021-06-09 | — | — | EP | disclosed |
| US-10280185-B2 | Mononuclear salen indium catalysts and methods of manufacture and use thereof | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2019-05-07 | — | — | US | disclosed |
| US-20170137442-A1 | MONONUCLEAR SALEN INDIUM CATALYSTS AND METHODS OF MANUFACTURE AND USE THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2017-05-18 | — | — | US | disclosed |
| US-20170137442-A1 | MONONUCLEAR SALEN INDIUM CATALYSTS AND METHODS OF MANUFACTURE AND USE THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2017-05-18 | — | — | US | disclosed |
| WO-2016000071-A1 | MONONUCLEAR SALEN INDIUM CATALYSTS AND METHODS OF MANUFACTURE AND USE THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2016-01-07 | — | — | WO | disclosed |
| WO-2015113168-A1 | CRYSTALLINE POLY(LACTIC ACID) AND PROCESS FOR PRODUCTION THEREOF | GREENCENTRE CANADA (CA) | 2015-08-06 | — | — | WO | disclosed |
| WO-2013134877-A1 | SALEN INDIUM CATALYSTS AND METHODS OF MANUFACTURE AND USE THEREOF | GREENCENTRE CANADA (CA) | 2013-09-19 | — | — | WO | disclosed |
| EP-1982972-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-10-22 | — | — | EP | disclosed |
| EP-1982973-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-10-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10280185-B2 | Mononuclear salen indium catalysts and methods of manufacture and use thereof | LDHA, LDHB, IDH1 | L3MBTL1 3825/4885BCHE 1581/4885ACHE 737/4885 |
| US-20170137442-A1 | MONONUCLEAR SALEN INDIUM CATALYSTS AND METHODS OF MANUFACTURE AND USE THEREOF | LDHA, LDHB, IDH1 | L3MBTL1 3825/4885BCHE 1581/4885ACHE 737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.